Nationwide Estrogen Patch Shortage Impacted Patients
If you are currently using estrogen patches for menopause symptoms, talk to your doctor about availability and potential alternatives.
Updated on Oct. 6, 2026 in Women’s Health
Live Poll
Do you trust that health systems can reliably provide the medications you need for chronic conditions?
On September 3, 2026, the FDA acknowledged that patients across the United States have faced difficulty accessing estrogen patches. This shortage, which is driven by supply chain issues and rising demand, has prompted federal officials to coordinate with manufacturers to increase the national supply.
Why it matters
Estrogen patches are a primary treatment for menopause symptoms, and supply disruptions can cause significant challenges for symptom management. Federal coordination with suppliers is currently underway to stabilize the availability of these medications for patients nationwide.
The FDA confirmed the ongoing supply shortage on September 3, 2026, involving six manufacturers. While federal agencies are working to ramp up production, the specific date for full inventory restoration remains unknown.
The players
Food and Drug Administration
The federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human drugs and medical devices.
The details
Estrogen patches work by delivering consistent levels of hormone therapy through the skin to manage menopause symptoms. When supply chain issues or increased demand disrupt manufacturing, patients may experience gaps in care. In some clinical instances, physicians may suggest sublingual estradiol pills as an alternative, though such changes should always be managed through direct consultation with a healthcare provider.
Timeline
September 3, 2026: The FDA officially acknowledged patient difficulty accessing estrogen patches.
Health Landscape
This shortage reflects a broader trend of supply chain fragility affecting widely used hormone replacement therapies in the United States. It follows the standard regulatory pattern of the FDA drug shortage reporting requirements to coordinate manufacturing responses for essential medications.
If you are having trouble filling your prescription, do not stop your treatment abruptly; instead, reach out to your pharmacy or physician to discuss if sublingual estradiol pills are appropriate for you. Keep a record of your refill dates and maintain open communication with your doctor about potential delays in your care.
The takeaway
When medication supplies are disrupted, the most important step is to avoid self-adjusting your treatment plan. Always consult your physician before switching to an alternative delivery method like pills, as they can provide the guidance necessary to safely transition your care during a shortage.
Further reading
For more information on managing hormone therapy, visit our Women’s Health section.
Source note: This article includes information reported by KOBI-TV NBC5 / KOTI-TV NBC2.
Live Poll
Do you trust that health systems can reliably provide the medications you need for chronic conditions?
